A jury has awarded $30 million -- the largest med-mal verdict awarded by a Philadelphia panel in recent years -- to the family of a 5-year-old boy whose severe cognitive and developmental deficiencies were alleged to have resulted from the misadministration of a blood-clot-busting medication. However, the actual disposition amount in the case is officially under wraps, as the parties reached a confidential high-low agreement shortly after the jury began deliberations.
Font Size:
![]()
Jury Awards $30M in Med-Mal Suit, but High-Low Hides Outcome
The Legal Intelligencer
June 13, 2006
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.







